Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
$12.35
-0.2%
$12.46
$11.75
$25.36
$572.50M1.12382,361 shs144,217 shs
FibroGen, Inc stock logo
FGEN
FibroGen
$5.69
+8.4%
$7.21
$4.50
$38.25
$21.22M0.7476,019 shs33,072 shs
Veradigm Inc. stock logo
MDRX
Veradigm
$4.85
+3.2%
$4.40
$3.00
$11.80
$525.09M0.77333,765 shs2,738 shs
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$23.94
$23.89
$15.23
$23.98
$1.61B0.77659,586 shsN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
+0.01%+1.69%-0.60%-7.94%-36.41%
FibroGen, Inc stock logo
FGEN
FibroGen
+8.38%+7.36%-24.46%-18.71%-67.06%
Veradigm Inc. stock logo
MDRX
Veradigm
0.00%+7.78%+12.79%+21.25%-48.95%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
2.4944 of 5 stars
0.03.00.00.02.71.72.5
FibroGen, Inc stock logo
FGEN
FibroGen
4.7195 of 5 stars
3.33.00.04.74.43.30.6
Veradigm Inc. stock logo
MDRX
Veradigm
3.1637 of 5 stars
3.00.00.04.12.80.00.0
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
0.00
N/AN/AN/A
FibroGen, Inc stock logo
FGEN
FibroGen
2.50
Moderate Buy$250.004,293.67% Upside
Veradigm Inc. stock logo
MDRX
Veradigm
2.00
Hold$13.00168.04% Upside
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NXGN, MDRX, AVNS, and FGEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
FibroGen, Inc stock logo
FGEN
FibroGen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$250.00 ➝ $250.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
$687.80M0.83$11.88 per share1.04$18.03 per share0.68
FibroGen, Inc stock logo
FGEN
FibroGen
$29.62M0.78N/AN/A($50.89) per share-0.11
Veradigm Inc. stock logo
MDRX
Veradigm
$1.53B0.34N/AN/AN/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$653.17M2.46$1.16 per share20.57$6.31 per share3.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
-$392.10M-$8.37N/A7.14N/A-55.80%6.26%4.63%7/30/2025 (Estimated)
FibroGen, Inc stock logo
FGEN
FibroGen
-$47.58M-$2.50N/AN/AN/A-9.73%N/A-24.77%8/5/2025 (Estimated)
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/A0.00N/AN/AN/AN/AN/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
-$2.65M-$0.10N/A27.52N/A-0.89%11.37%5.38%N/A

Latest NXGN, MDRX, AVNS, and FGEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
$0.18N/AN/AN/A$165.50 millionN/A
5/12/2025Q1 2025
FibroGen, Inc stock logo
FGEN
FibroGen
$0.75-$4.00-$4.75$0.05$2.00 million$2.70 million
5/6/2025Q1 2025
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
$0.19$0.26+$0.07$0.14$161.75 million$167.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
N/AN/AN/AN/AN/A
FibroGen, Inc stock logo
FGEN
FibroGen
N/AN/AN/AN/AN/A
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/AN/AN/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
0.12
2.57
1.56
FibroGen, Inc stock logo
FGEN
FibroGen
N/A
2.02
1.98
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.63
2.52
2.52

Institutional Ownership

CompanyInstitutional Ownership
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
95.17%
FibroGen, Inc stock logo
FGEN
FibroGen
72.71%
Veradigm Inc. stock logo
MDRX
Veradigm
N/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
76.65%

Insider Ownership

CompanyInsider Ownership
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
2.64%
FibroGen, Inc stock logo
FGEN
FibroGen
3.07%
Veradigm Inc. stock logo
MDRX
Veradigm
2.29%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
4.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
AVANOS MEDICAL, INC. stock logo
AVNS
AVANOS MEDICAL
2,22746.24 million45.02 millionOptionable
FibroGen, Inc stock logo
FGEN
FibroGen
5704.04 million3.92 millionOptionable
Veradigm Inc. stock logo
MDRX
Veradigm
8,000108.27 million105.18 millionNo Data
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
2,78367.10 million64.01 millionOptionable

Recent News About These Companies

Vikas Jain Takes Helm at NAREDCO Maharashtra NextGen

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVANOS MEDICAL stock logo

AVANOS MEDICAL NYSE:AVNS

$12.35 -0.03 (-0.24%)
As of 07/3/2025 03:30 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

FibroGen stock logo

FibroGen NASDAQ:FGEN

$5.69 +0.44 (+8.38%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$5.61 -0.08 (-1.41%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Veradigm stock logo

Veradigm NASDAQ:MDRX

$4.85 +0.15 (+3.19%)
As of 07/3/2025 11:22 AM Eastern

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

NextGen Healthcare stock logo

NextGen Healthcare NASDAQ:NXGN

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.